New funding allows JDRF’s prevention research to go deeper
Published on April 9, 2018

Two promising Australian research projects have been awarded almost $3 million in funding from The Leona M. and Harry B. Helmsley Charitable Trust, to be administered by JDRF Australia. A prestigious partnership                                                                  The Helmsley Charitable Trust is one of the largest medical research-funding philanthropic trusts in the world. Helmsley has provided more than US$1.5 billion of grants since […]

Thirteen type 1 diabetes research rising stars announced
Published on March 2, 2018

JDRF is pleased to announce the next group of participants taking part in the JDRF/Macquarie Group Foundation Future Research Leaders Program (FRLP). An initiative of JDRF and principally supported by the Macquarie Group Foundation, this Program aims to support researchers in the early-mid stages of their careers to develop leadership potential and increase the success […]

Immune cells seen flocking to the pancreas in type 1 diabetes
Published on February 25, 2018

Researchers from Europe have discovered that people with type 1 diabetes (T1D) have more beta cell-targeting immune cells in the pancreas than people without T1D. This is an interesting finding given that both groups have similar numbers of immune cells overall. This knowledge helps researchers further understand the process leading to T1D.

Australian research confirms a gut feeling
Published on February 22, 2018

Recent research part-funded by JDRF and led by Dr Emma-Hamilton Williams from the University of Queensland found that targeting microorganisms in the gut has the potential to prevent type 1 diabetes. The microorganism population in your gut, including bacteria and viruses, is known as the microbiome. Many of the microorganisms help us – for example, […]

Insulin pump system found to reduce hypos
Published on February 2, 2018

New research funded by JDRF’s T1DCRN has found a pump that suspends insulin delivery when blood glucose levels fall can halve time spent in hypoglycaemia (low blood sugar) in young people living with type 1 diabetes (T1D). Integrating real-time continuous glucose monitoring systems (CGM) and pump therapy has been an important milestone in the management of […]

Our greatest research moments of 2017
Published on February 1, 2018

As we embark on a brand new calendar year, let’s take a moment to pause and reflect on some advances in type 1 diabetes research from the previous 12 months. We’re closer to a cure than we were one year ago, and we have laid the groundwork for further success in 2018. In 2017, JDRF […]

When viruses use their powers for good
Published on January 25, 2018

A study partly-funded by JDRF has found that viruses could be the answer for the survival of insulin-producing beta cells. This approach could combat type 1 diabetes. Researchers at the University of Pittsburgh were able to restore normal blood glucose levels in mice using a virus carrying two genes. These genes contained instructions for two […]

JDRF secures new talent for type 1 diabetes clinical research
Published on December 4, 2017

JDRF is pleased to announce the recipients of the Type 1 Diabetes Clinical Research Network’s (T1DCRN) Mentored Clinician Researcher Fellowship Award (MCRF) for 2017. The T1DCRN is an innovative clinical research program led by JDRF Australia and funded by a Special Research Initiative through the Australian Research Council (ARC). One of the key objectives of […]

Future Research Leaders: Meet Dr Esteban Gurzov
Published on November 30, 2017

Dr Esteban Gurzov is one of the first participants to be part of the JDRF/Macquarie Group Foundation Future Research Leaders Pilot Program. Dr Esteban Gurzov fell in love with science as a young boy when his Dad bought him Carl Sagan’s book Cosmos. He was hooked, writing letters to NASA and waiting anxiously for the […]